Page last updated: 2024-11-02

piribedil and Bradycardia

piribedil has been researched along with Bradycardia in 1 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.

Research Excerpts

ExcerptRelevanceReference
"No studies have previously reported the simultaneous observation of position-unrelated hypotension and bradycardia after taking small doses of piribedil."8.98Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review. ( Li, Y; Nie, K; Wang, L; Zhang, P; Zhang, Y, 2018)
"No studies have previously reported the simultaneous observation of position-unrelated hypotension and bradycardia after taking small doses of piribedil."4.98Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review. ( Li, Y; Nie, K; Wang, L; Zhang, P; Zhang, Y, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, P1
Li, Y1
Nie, K1
Wang, L1
Zhang, Y1

Reviews

1 review available for piribedil and Bradycardia

ArticleYear
Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review.
    BMC neurology, 2018, Dec-27, Volume: 18, Issue:1

    Topics: Bradycardia; Dopamine; Dopamine Agonists; Humans; Hypotension; Male; Middle Aged; Parkinson Disease;

2018